Handa Pharmaceuticals, Inc. (TPEX:6620)

Handa Pharmaceuticals Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	597.38	667.05	365.91	263.31	280.12
Short-Term Investments	1,232	1,650	-	19.96	34.98
Cash & Short-Term Investments	1,829	2,317	365.91	283.27	315.09
Cash Growth	-21.04%	533.18%	29.18%	-10.10%	-50.47%
Accounts Receivable	190.44	376.37	153.48	7.79	21.64
Other Receivables	29.29	6.74	8.02	7.62	6.08
Receivables	219.73	383.11	161.51	15.4	27.72
Inventory	41.24	-	-	-	-
Prepaid Expenses	12.16	11.63	2.42	2.33	22.38
Other Current Assets	2.66	3.27	63.02	13.34	43.7
Total Current Assets	2,105	2,715	592.86	314.33	408.9
Property, Plant & Equipment	75.78	21.03	43.04	41.83	44.78
Long-Term Investments	62.2	61.86	-	-	-
Goodwill	35.93	34.95	34.95	34.95	34.95
Other Intangible Assets	917.05	0.59	1.07	1.31	-
Long-Term Deferred Tax Assets	243.52	202.85	117.23	105.18	91.08
Other Long-Term Assets	1.72	1.04	1.43	0.93	2.73
Total Assets	3,441	3,037	790.56	498.53	582.44
Accounts Payable	20.78	13.97	6.22	1.08	9.36
Accrued Expenses	35.42	51.38	18.53	14.61	17.59
Current Portion of Leases	7.27	5.57	10.14	6.2	7.82
Current Income Taxes Payable	-	124.76	1.34	0.01	0.01
Other Current Liabilities	177.89	13.81	9.13	7.84	3.12
Total Current Liabilities	241.36	209.49	45.35	29.73	37.9
Long-Term Leases	32.83	7.67	19.46	5.7	5.54
Long-Term Unearned Revenue	39.43	-	-	-	-
Long-Term Deferred Tax Liabilities	7.28	23.81	4.63	-	-
Other Long-Term Liabilities	3.19	39.92	-	-	-
Total Liabilities	324.09	280.88	69.44	35.43	43.44
Common Stock	1,412	1,411	1,302	1,221	1,157
Additional Paid-In Capital	1,254	1,253	579.02	338.41	231.74
Retained Earnings	546.87	215.2	-1,089	-1,049	-801
Treasury Stock	-56.52	-	-	-	-
Comprehensive Income & Other	-39.45	-123.18	-70.76	-47.93	-48.76
Shareholders' Equity	3,117	2,756	721.12	463.1	539
Total Liabilities & Equity	3,441	3,037	790.56	498.53	582.44
Total Debt	40.1	13.24	29.59	11.89	13.36
Net Cash (Debt)	1,789	2,304	336.32	271.38	301.73
Net Cash Growth	-22.33%	584.95%	23.93%	-10.06%	-51.01%
Net Cash Per Share	12.68	17.10	2.68	2.31	2.61
Filing Date Shares Outstanding	140.48	141.09	130.16	122.13	115.7
Total Common Shares Outstanding	140.48	141.09	130.16	122.13	115.7
Working Capital	1,864	2,505	547.5	284.61	371
Book Value Per Share	22.19	19.54	5.54	3.79	4.66
Tangible Book Value	2,164	2,721	685.11	426.85	504.05
Tangible Book Value Per Share	15.41	19.28	5.26	3.50	4.36
Machinery	76.25	68.61	66.98	76.07	70.51
Leasehold Improvements	-	-	15.54	15.49	15.79

Updated Aug 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.